Differential effects of omega-3 and omega-6 fatty acids on gene expression in breast cancer cells

Breast Cancer Research and Treatment

Volumn 101, Issue 1, 2007, Pages 7-16

  Hammamieh, Rasha ^a   Chakraborty, Nabarun ^a   Miller, Stacy Ann ^a   Waddy, Edward ^a   Barmada, Mohsen ^a   Das, Rina ^a   Peel, Sheila A ^a   Day, Agnes A ^b   Jett, Marti ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Arachidonic acid (AA); DNA microarray; Eicosapentaenoic acid (EPA); N 3 polyunsaturated fatty acid; N 6 polyunsaturated fatty acid

Indexed keywords

ARACHIDONIC ACID; COMPLEMENTARY DNA; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL ADHESION; CELL DIVISION; CELL PROLIFERATION; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; GLYCOSYLATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION; BREAST TUMOR; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METHODOLOGY; PATHOLOGY; PRINCIPAL COMPONENT ANALYSIS; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRINCIPAL COMPONENT ANALYSIS;

EID: 34250848267     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10549-006-9269-x     Document Type: Article

References (28)

1. Apantaku LM (2000) Breast cancer diagnosis and screening. Am Fam Physician 62(3):596-602, 605-606
2. Apantaku LM (2002) Breast-conserving surgery for breast cancer. Am Fam Physician 66(12): 2271-2278
3. Carroll KK (1985) Dietary fat in relation to mammary carcinogenesis. Princess Takamatsu Symp 16:255-263
4. Enig MG, Munn RJ, Keeney M (1978) Dietary fat and cancer trends-a critique. Fed Proc 37(9):2215-2220
5. Hilakivi-Clarke L, Olivo SE, Shajahan A, Khan G, Zhu Y, Zwart A, Cho E, Clarke R (2005) Mechanisms mediating the effects of prepubertal (n-3) polyunsaturated fatty acid diet on breast cancer risk in rats. J Nutr 135(12 Suppl):2946S-2952S
6. Schley PD, Jijon HB, Robinson LE, Field CJ (2005) Mechanisms of omega-3 fatty acid-induced growth inhibition in MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat 92(2):187-195
7. Wu M, Harvey KA, Ruzmetov N, Welch ZR, Sech L, Jackson K, Stillwell W, Zaloga GP, Siddiqui RA (2005) Omega-3 polyunsaturated fatty acids attenuate breast cancer growth through activation of a neutral sphingomyelinase-mediated pathway. Int J Cancer 117(3):340-348
8. Cohen LA (1997) Breast cancer risk in rats fed a diet high in n-6 polyunsaturated fatty acids during pregnancy. J Natl Cancer Inst 89(9):662-663
9. Lanson M, Bougnoux P, Besson P, Lansac J, Hubert B, Couet C, Le Floch O (1990) N-6 polyunsaturated fatty acids in human breast carcinoma phosphatidylethanolamine and early relapse. Br J Cancer 61(5):776-778
10. Chajes V, Sattler W, Stranzl A, Kostner GM (1995) Influence of n-3 fatty acids on the growth of human breast cancer cells in vitro: relationship to peroxides and vitamin-E. Breast Cancer Res Treat 34(3):199-212
11. Karmali RA (1989) n-3 fatty acids and cancer. J Intern Med Suppl 731:197-200
12. Grammatikos SI, Subbaiah PV, Victor TA, Miller WM (1994) n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell lines. Br J Cancer 70(2):219-227
13. Hammamieh R, Chakraborty N, Das R, Jett M (2004) Molecular impacts of antisense complementary to the liver fatty acid binding protein (FABP) mRNA in DU 145 prostate cancer cells in vitro. J Exp Ther Oncol 4(3):195-202
14. Esmon CT (2003) The protein C pathway. Chest 124(3 Suppl):26S-32S
15. Yin Y, Liu YX, Jin YJ, Hall EJ, Barrett JC (2003) PAC1 phosphatase is a transcription target of p53 in signalling apoptosis and growth suppression. Nature 422(6931): 527-531
16. Germani A, Prabel A, Mourah S, Podgorniak MP, Di Carlo A, Ehrlich R, Gisselbrecht S, Varin-Blank N, Calvo F, Bruzzoni-Giovanelli H (2003) SIAH-1 interacts with CtIP and promotes its degradation by the proteasome pathway. Oncogene 22(55):8845-8851
17. Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T, Tagawa M (2005) Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 115(3):437-442
18. Zhang Y, Pasparakis M, Kollias G, Simons M (1999) Myocyte-dependent regulation of endothelial cell syndecan-4 expression. Role of TNF-alpha. J Biol Chem 274(21):14,786-14,790
19. Lee BP, Rushlow WJ, Chakraborty C, Lala PK (2001) Differential gene expression in premalignant human trophoblast: role of IGFBP-5. Int J Cancer 94(5):674-684
20. Jensen LE, Whitehead AS (2003) Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. Cell Signal 15(8):793-802
21. Nagahata T, Sato T, Tomura A, Onda M, Nishikawa K, Emi M (2005) Identification of RAI3 as a therapeutic target for breast cancer. Endocr Relat Cancer 12(1):65-73
22. Pigott DA, Grimaldi MA, Dell'Aquila ML, Gaffney EV (1982) Growth inhibitors in plasma derived human serum. In Vitro 18(7):617-625
23. Cardoso F, Ross JS, Picart MJ, Sotiriou C, Durbecq V (2004) Targeting the ubiquitin-proteasome pathway in breast cancer. Clin Breast Cancer 5(2):148-157
24. Cloitre M, Heimberg RG, Holt CS, Liebowitz MR (1992) Reaction time to threat stimuli in panic disorder and social phobia. Behav Res Ther 30(6):609-617
25. Dennis JW, Laferte S, Yagel S, Breitman ML (1989) Asparagine-linked oligosaccharides associated with metastatic cancer. Cancer Cells 1(3):87-92
26. Xiang Q, Fan SQ, Li J, Tan C, Xiang JJ, Zhang QH, Wang R, Li GY (2002) [Expression of connexin43 and connexin45 in nasopharyngeal carcinoma]. Ai Zheng 21(6):593-596
27. Hodgson JG, Malek T, Bornstein S, Hariono S, Ginzinger DG, Muller WJ, Gray JW (2005) Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 65(21):9695-9704
28. Yokozaki H, Budillon A, Tortora G, Meissner S, Beaucage SL, Miki K, Cho-Chung YS (1993) An antisense oligodeoxynucleotide that depletes RI alpha subunit of cyclic AMP-dependent protein kinase induces growth inhibition in human cancer cells. Cancer Res 53(4):868-872